JP6016783B2 - 小ペプチドを含む細胞培養培地 - Google Patents

小ペプチドを含む細胞培養培地 Download PDF

Info

Publication number
JP6016783B2
JP6016783B2 JP2013506336A JP2013506336A JP6016783B2 JP 6016783 B2 JP6016783 B2 JP 6016783B2 JP 2013506336 A JP2013506336 A JP 2013506336A JP 2013506336 A JP2013506336 A JP 2013506336A JP 6016783 B2 JP6016783 B2 JP 6016783B2
Authority
JP
Japan
Prior art keywords
cells
cell culture
serum
free
cysteine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013506336A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013524817A (ja
JP2013524817A5 (enExample
Inventor
ショーン バレット
ショーン バレット
スコット ヤコビア
スコット ヤコビア
Original Assignee
ライフ テクノロジーズ コーポレーション
ライフ テクノロジーズ コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44816118&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6016783(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by ライフ テクノロジーズ コーポレーション, ライフ テクノロジーズ コーポレーション filed Critical ライフ テクノロジーズ コーポレーション
Publication of JP2013524817A publication Critical patent/JP2013524817A/ja
Publication of JP2013524817A5 publication Critical patent/JP2013524817A5/ja
Application granted granted Critical
Publication of JP6016783B2 publication Critical patent/JP6016783B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2013506336A 2010-04-23 2011-04-22 小ペプチドを含む細胞培養培地 Active JP6016783B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32764410P 2010-04-23 2010-04-23
US61/327,644 2010-04-23
US13/092,016 US20110262965A1 (en) 2010-04-23 2011-04-21 Cell culture medium comprising small peptides
US13/092,016 2011-04-21
PCT/US2011/033630 WO2011133902A2 (en) 2010-04-23 2011-04-22 Cell culture medium comprising small peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016131248A Division JP2017006127A (ja) 2010-04-23 2016-07-01 小ペプチドを含む細胞培養培地

Publications (3)

Publication Number Publication Date
JP2013524817A JP2013524817A (ja) 2013-06-20
JP2013524817A5 JP2013524817A5 (enExample) 2014-05-29
JP6016783B2 true JP6016783B2 (ja) 2016-10-26

Family

ID=44816118

Family Applications (7)

Application Number Title Priority Date Filing Date
JP2013506336A Active JP6016783B2 (ja) 2010-04-23 2011-04-22 小ペプチドを含む細胞培養培地
JP2016131248A Withdrawn JP2017006127A (ja) 2010-04-23 2016-07-01 小ペプチドを含む細胞培養培地
JP2016220107A Active JP6367293B2 (ja) 2010-04-23 2016-11-11 小ペプチドを含む細胞培養培地
JP2018089250A Pending JP2018113996A (ja) 2010-04-23 2018-05-07 小ペプチドを含む細胞培養培地
JP2020102940A Active JP7200180B2 (ja) 2010-04-23 2020-06-15 小ペプチドを含む細胞培養培地
JP2022147887A Active JP7481407B2 (ja) 2010-04-23 2022-09-16 小ペプチドを含む細胞培養培地
JP2024071297A Pending JP2024099021A (ja) 2010-04-23 2024-04-25 小ペプチドを含む細胞培養培地

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2016131248A Withdrawn JP2017006127A (ja) 2010-04-23 2016-07-01 小ペプチドを含む細胞培養培地
JP2016220107A Active JP6367293B2 (ja) 2010-04-23 2016-11-11 小ペプチドを含む細胞培養培地
JP2018089250A Pending JP2018113996A (ja) 2010-04-23 2018-05-07 小ペプチドを含む細胞培養培地
JP2020102940A Active JP7200180B2 (ja) 2010-04-23 2020-06-15 小ペプチドを含む細胞培養培地
JP2022147887A Active JP7481407B2 (ja) 2010-04-23 2022-09-16 小ペプチドを含む細胞培養培地
JP2024071297A Pending JP2024099021A (ja) 2010-04-23 2024-04-25 小ペプチドを含む細胞培養培地

Country Status (10)

Country Link
US (6) US20110262965A1 (enExample)
EP (4) EP3165600B1 (enExample)
JP (7) JP6016783B2 (enExample)
KR (6) KR20170051527A (enExample)
CN (3) CN106520658B (enExample)
AU (6) AU2011242496C1 (enExample)
DE (1) DE202011110859U1 (enExample)
DK (3) DK3168295T3 (enExample)
SG (3) SG10201609347RA (enExample)
WO (1) WO2011133902A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130130317A1 (en) * 2010-08-02 2013-05-23 Kyowa Hakko Kirin Co., Ltd Method for producing substance
SG187198A1 (en) * 2010-08-05 2013-03-28 Amgen Inc Dipeptides to enhance yield and viability from cell cultures
EP2702077A2 (en) 2011-04-27 2014-03-05 AbbVie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
JP6216327B2 (ja) 2011-12-22 2017-10-18 ライフ テクノロジーズ コーポレーション 細胞培地および方法
CN102533634A (zh) * 2012-02-22 2012-07-04 江阴剑桥生物技术有限公司 Cho细胞无血清无蛋白化学培养基
JP6070693B2 (ja) * 2012-03-30 2017-02-01 味の素株式会社 硫酸化化合物を含む幹細胞増殖用培地
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
WO2013158279A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Protein purification methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
EP2844737B1 (en) 2012-05-02 2018-03-21 Life Technologies Corporation High yield transient expression in mammalian cells using unique pairing of high density growth and transfection medium and expression enhancers
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
CA2905010A1 (en) 2013-03-12 2014-09-18 Abbvie Inc. Human antibodies that bind human tnf-alpha and methods of preparing the same
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
JP6195191B2 (ja) * 2013-08-08 2017-09-13 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株を用いた組換えタンパク質の製造方法
JP6190205B2 (ja) * 2013-08-08 2017-08-30 極東製薬工業株式会社 無タンパク質・無脂質培地馴化細胞株、その製造方法及び培地
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9534026B2 (en) * 2013-10-31 2017-01-03 China National Research Institute Of Food & Fermentation Industries Corn active peptide additive for cell culture medium
CN104593318B (zh) * 2013-10-31 2018-05-04 中国食品发酵工业研究院 一种用于细胞培养基的玉米活性肽添加剂
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
CN106459907B (zh) 2014-04-10 2020-11-06 拜尔健康护理有限责任公司 复合培养基粉末制剂和制备用于细胞培养的液体培养基的方法
CA2948845C (en) * 2014-05-14 2022-05-31 Merial, Inc. Methods for freeze-drying and rehydrating biologics
SG11201609980TA (en) * 2014-06-18 2016-12-29 Medimmune Llc Cell culture methods and media comprising n-acetylcysteine
RU2725191C2 (ru) 2014-08-11 2020-06-30 Ф. Хоффманн-Ля Рош Аг Способ повышения удельной скорости и продуцирования в эукариотических клетках
EP3303555B1 (en) * 2015-05-29 2020-06-24 Merck Patent GmbH Deep eutectic solvents and/or ionic liquids in cell culture media
CA3000926A1 (en) * 2015-11-02 2017-05-11 Ares Trading S.A. Methods for modulating production profiles of recombinant proteins in perfusion mode
WO2017146646A1 (en) * 2016-02-22 2017-08-31 Agency For Science, Technology And Research Cell culture medium
CN107760651A (zh) * 2016-08-23 2018-03-06 四川科伦博泰生物医药股份有限公司 一种细胞培养基及生产蛋白质的方法
DE102017203908B3 (de) * 2017-03-09 2018-05-30 Evonik Technochemie Gmbh Kulturmedium, umfassend Oligopeptide
EP3372671B1 (en) 2017-03-09 2021-11-03 Evonik Operations GmbH Culture medium comprising olgopeptides
ES2724434T3 (es) * 2017-03-09 2019-09-10 Evonik Technochemie Gmbh Medios de cultivo que comprenden dipéptidos de N-acil-X-glutamina
JP7181534B2 (ja) * 2017-03-28 2022-12-01 味の素株式会社 未分化維持培地添加剤
CN106978390B (zh) * 2017-05-22 2020-11-13 广东顺德工业设计研究院(广东顺德创新设计研究院) 适用于贴壁型cho细胞的无血清培养基及培养方法
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
CN107278892A (zh) * 2017-06-26 2017-10-24 浦江县美泽生物科技有限公司 紫玉兰的高效组织培养方法
JP7117374B2 (ja) * 2017-10-13 2022-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 灌流培地
EP3710574A1 (en) * 2017-11-16 2020-09-23 Life Technologies Corporation Streamlined methods for making liquid media
WO2019121053A1 (en) * 2017-12-20 2019-06-27 Basf Se A method for stabilizing cell culture systems using an amphiphilic graft copolymer as cell culture reagent
US12454678B2 (en) * 2018-06-29 2025-10-28 Nagase & Co., Ltd. Muscle differentiation-promoting actions of ergothioneine, ascorbic acid 2-glucoside, ascorbic acid, and combination thereof
JP7197339B2 (ja) * 2018-12-05 2022-12-27 アサヒグループ食品株式会社 コク味付与物質含有酵母の製造方法及びコク味付与物質含有酵母エキスの製造方法
CN109628378B (zh) * 2019-01-25 2020-07-17 江苏丰华生物制药有限公司 一种利用花生蛋白酶解物培养cho细胞的方法
JP2023522059A (ja) * 2020-04-20 2023-05-26 エボニック オペレーションズ ゲーエムベーハー Ｃｙｓ－ペプチドを含む組成物
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
CN117940556A (zh) * 2021-09-15 2024-04-26 赢创运营有限公司 包含二肽和微量元素的组合物
JP2024534727A (ja) 2021-10-05 2024-09-25 エボニック オペレーションズ ゲーエムベーハー ジペプチドの塩および細胞培養におけるそれらの使用
CN118804922A (zh) 2022-03-03 2024-10-18 赢创运营有限公司 使用甘氨酰-谷氨酰胺增强细胞培养中病毒载体生产的方法
KR20250008873A (ko) * 2022-05-12 2025-01-16 에보닉 오퍼레이션스 게엠베하 광안정화된 조성물 및 감광성 성분의 안정화 방법
KR20250149769A (ko) * 2023-02-16 2025-10-16 메르크 파텐트 게엠베하 세포 배양 배지
KR102609654B1 (ko) * 2023-03-23 2023-12-05 코스맥스 주식회사 인간 피부 유래 산물을 포함하는 미생물 배양 배지 및 이를 이용하여 배양된 혼합 미생물 배양액의 피부 개선 용도
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes
WO2025219232A1 (en) * 2024-04-15 2025-10-23 Evonik Operations Gmbh Application of small peptides supplemented cell culture media for improved cell performance
CN118956737A (zh) * 2024-07-17 2024-11-15 广州沃亘生物科技有限公司 一种长期维持df-1细胞活力的培养基及其用途

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235772A (en) * 1978-06-21 1980-11-25 Ab Kabi Novel peptides having growth promoting activity
DE3206810C2 (de) 1982-02-25 1983-12-29 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen N ↑2↑-L-Tyrosinyl-N ↑6↑-L-tyrosinyl-L-lysin und N ↑2↑-L-Cystinyl-N ↑6↑-L-cystinyl-L-lysin, Verfahren zu deren Herstellung und deren Verwendung
DE3206784C2 (de) * 1982-02-25 1985-05-09 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Glutaminhaltige Zubereitungen für orale oder intravenöse Applikation
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
EP0243469A4 (en) * 1985-10-22 1988-02-16 Plant Genetics Inc Methods and media for enhanced somatic embryogenesis.
DE3538310A1 (de) 1985-10-28 1987-04-30 Pfrimmer Pharma Verwendung von glutamin in form seiner di- und tripeptide im naehrmedium fuer zellkulturen
WO1988003150A2 (en) 1986-10-24 1988-05-05 Pfrimmer + Co. Pharmazeutische Werke Erlangen Gmbh N,n'-bis-amino acid-l-cystine-peptide-containing amino acid preparations for oral and parenteral administration
JPH05507472A (ja) * 1990-04-23 1993-10-28 リサーチ・コーポレイション・テクノロジーズ・インコーポレイテッド 経静脈栄養法のためのチロシン、システイン、グルタミンの可溶性で安定な供給源
US5206220A (en) 1990-04-23 1993-04-27 Research Corporation Technologies, Inc. Soluble and stable sources of tyrosine, cysteine and glutamine for total parenteral nutrition
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
DE4022267C2 (de) * 1990-07-12 1994-09-15 Degussa N-Acyldipeptide und deren Verwendung
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB2251249B (en) 1990-12-28 1995-06-21 Mogam Biotech Res Inst High-density medium for animal cell culture
EP0811056B1 (en) * 1995-02-23 2000-05-31 Quest International B.V. Peptides for tissue and cell culture media
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
EP2243827B2 (en) 1996-08-30 2017-11-22 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
US20030130195A1 (en) * 2000-01-27 2003-07-10 Universite Laval Enzymatic hydrolysate of milk proteins
US6759510B1 (en) 2000-06-30 2004-07-06 Becton, Dickinson And Company Peptides for use in culture media
CN1592752A (zh) * 2000-12-20 2005-03-09 诺瓦提斯公司 用于治疗癌症的e2f－1/细胞周期蛋白相互作用的抑制剂
US20030096414A1 (en) 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
WO2003046141A2 (en) * 2001-11-26 2003-06-05 Advanced Cell Technology, Inc. Methods for making and using reprogrammed human somatic cell nuclei and autologous and isogenic human stem cells
WO2003085138A1 (en) 2002-03-29 2003-10-16 Merck & Co., Inc. Methods of virus production
KR101088223B1 (ko) * 2002-12-23 2011-11-30 브리스톨-마이어스 스큅 컴퍼니 단백질 생산을 위한 포유류 세포 배양 방법에서의 생산물품질 향상
US7193038B2 (en) * 2003-02-28 2007-03-20 National Institute Of Agrobiological Sciences Extraction and utilization of cell growth-promoting peptides from silk protein
WO2006028480A1 (en) * 2004-09-07 2006-03-16 Clonex Development, Inc. Cell lines for use in increasing protein yield form a cell culture
US20050287666A1 (en) 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
US7294484B2 (en) 2004-08-27 2007-11-13 Wyeth Research Ireland Limited Production of polypeptides
EP1829968A4 (en) * 2004-12-20 2008-09-10 Ajinomoto Kk PROTEIN MUTANT WITH PEPTIDE PRODUCTION ACTIVITY
EP2500413A1 (en) * 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
EP2069480B1 (en) * 2006-09-15 2014-03-19 MedImmune, LLC Mdck cell lines supporting viral growth to high titers and bioreactor process using the same
WO2008035631A1 (fr) * 2006-09-20 2008-03-27 Kyowa Hakko Kogyo Co., Ltd. Procédé de production d'une substance
KR101523782B1 (ko) * 2006-11-08 2015-05-28 와이어쓰 엘엘씨 세포 배양을 위한 합리적으로 설계된 배지
TWI601823B (zh) 2007-04-26 2017-10-11 Chugai Pharmaceutical Co Ltd Cell culture methods using media containing high concentrations of amino acids
JP2008276843A (ja) 2007-04-27 2008-11-13 Hitachi Ltd レーザー駆動方法及び光ディスク記録再生装置
CA2687082C (en) * 2007-05-11 2014-01-14 Amgen Inc. Improved feed media
US20110212489A1 (en) 2007-08-03 2011-09-01 Campina Nederland Holding B.V. Culture medium for eukaryotic cells
JP4911523B2 (ja) * 2007-10-22 2012-04-04 国立大学法人群馬大学 温度応答性配列を含むデプシペプチド構造と親水性高分子構造からなるブロック共重合体
WO2009060620A1 (ja) * 2007-11-08 2009-05-14 Fujifilm Corporation ポリペプチドの製造方法
JP5270239B2 (ja) 2008-07-08 2013-08-21 不二製油株式会社 ペプチド性脂質低下剤
EP2351833B1 (en) 2008-10-28 2018-07-18 Chugai Seiyaku Kabushiki Kaisha Peptide-containing culture medium for culturing animal cell
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US20130130317A1 (en) * 2010-08-02 2013-05-23 Kyowa Hakko Kirin Co., Ltd Method for producing substance
SG187198A1 (en) * 2010-08-05 2013-03-28 Amgen Inc Dipeptides to enhance yield and viability from cell cultures

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10793827B2 (en) 2010-04-23 2020-10-06 Life Technologies Corporation Cell culture medium comprising small peptides
US11365389B2 (en) 2010-04-23 2022-06-21 Life Technologies Corporation Cell culture medium comprising small peptides

Also Published As

Publication number Publication date
US20220275325A1 (en) 2022-09-01
JP7481407B2 (ja) 2024-05-10
KR20170089027A (ko) 2017-08-02
US20110262965A1 (en) 2011-10-27
JP2022171839A (ja) 2022-11-11
JP2024099021A (ja) 2024-07-24
DK3168295T3 (da) 2022-11-21
CN106520658B (zh) 2024-09-24
SG10201503196VA (en) 2015-06-29
US20200308537A1 (en) 2020-10-01
JP2018113996A (ja) 2018-07-26
DE202011110859U1 (de) 2016-12-20
AU2016256736A1 (en) 2016-12-01
US20230365919A1 (en) 2023-11-16
AU2011242496B2 (en) 2015-11-19
KR20170051527A (ko) 2017-05-11
JP2017006127A (ja) 2017-01-12
AU2016200611A1 (en) 2016-02-18
AU2016256736B2 (en) 2018-11-01
CN106520658A (zh) 2017-03-22
KR20180023019A (ko) 2018-03-06
KR101733834B1 (ko) 2017-05-08
AU2018202612B2 (en) 2020-10-29
DK2561065T3 (en) 2017-02-13
JP2013524817A (ja) 2013-06-20
EP2561065A2 (en) 2013-02-27
EP4170016A1 (en) 2023-04-26
AU2011242496A1 (en) 2012-10-25
KR102264580B1 (ko) 2021-06-11
AU2011242496C1 (en) 2017-03-09
US11365389B2 (en) 2022-06-21
JP6367293B2 (ja) 2018-08-01
AU2018202612A1 (en) 2018-05-10
JP2017060496A (ja) 2017-03-30
SG184936A1 (en) 2012-11-29
CN110205282A (zh) 2019-09-06
US20170058256A1 (en) 2017-03-02
CN102892878A (zh) 2013-01-23
AU2021200418B2 (en) 2023-05-25
KR101832795B1 (ko) 2018-02-28
US10793827B2 (en) 2020-10-06
CN110205282B (zh) 2024-07-05
EP3165600A1 (en) 2017-05-10
JP2020137529A (ja) 2020-09-03
KR101831549B1 (ko) 2018-02-22
EP3168295A1 (en) 2017-05-17
WO2011133902A3 (en) 2012-04-19
EP2561065B1 (en) 2016-11-09
KR20130106762A (ko) 2013-09-30
AU2021200418A1 (en) 2021-02-25
EP3165600B1 (en) 2022-11-02
WO2011133902A2 (en) 2011-10-27
KR20160138316A (ko) 2016-12-02
US20170342371A1 (en) 2017-11-30
KR20200051847A (ko) 2020-05-13
SG10201609347RA (en) 2017-01-27
JP7200180B2 (ja) 2023-01-06
KR102109463B1 (ko) 2020-05-12
AU2018202222A1 (en) 2018-04-26
EP2561065A4 (en) 2013-07-03
DK3165600T3 (da) 2022-12-05
EP3168295B1 (en) 2022-11-02

Similar Documents

Publication Publication Date Title
JP7481407B2 (ja) 小ペプチドを含む細胞培養培地

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140414

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140414

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20150323

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150617

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150914

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151028

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20151028

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20160302

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160701

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20160726

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160829

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160927

R150 Certificate of patent or registration of utility model

Ref document number: 6016783

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250